Downregulation of microglial activation by achillolide A

Pharmacology, Toxicology and Pharmaceutical Science

• Achillea 50%
• Anti-Inflammatory Drug 50%
• Antioxidant Capacity 50%
• Chronic Inflammation 50%
• Cyclooxygenase 2 50%
• Degenerative Disease 100%
• Gelatinase B 50%
• Glutamic Acid 50%
• Interleukin 1 50%
• Lipopolysaccharide 100%
• Nitric Oxide 50%
• Nitric Oxide Synthase 50%
• Pathogenesis 50%
• Primary Culture 50%
• Reactive Oxygen Metabolite 50%
• Sesquiterpene Lactone 50%
• Tumor Necrosis Factor 50%

Medicine and Dentistry

• Anti-Inflammatory Drug 33%
• Antioxidant Capacity 33%
• Chronic Inflammation 33%
• Cyclooxygenase 2 33%
• Degenerative Disease 66%
• Downregulation 100%
• Gelatinase B 33%
• Glutamic Acid 33%
• Interleukin 1 33%
• Lipopolysaccharide 66%
• Mediator 66%
• Microglia 100%
• Nitric Oxide 33%
• Nitric Oxide Synthase 33%
• Pathogenesis 33%
• Primary Culture 33%
• Reactive Oxygen Species 33%
• Sesquiterpene Lactone 33%
• Tumor Necrosis Factor 33%

Keyphrases

• Achillea Fragrantissima 20%
• Achillolide A 100%
• Activity-guided Fractionation 20%
• Anti-inflammatory Drugs 20%
• Antioxidant Capacity 20%
• Cell Release 20%
• Cell-free System 20%
• Chronic Inflammation 20%
• Cyclooxygenase-2 20%
• Glutamate 20%
• Induced Nitric Oxide Synthase 20%
• Inflammatory Mediators 20%
• Interleukin-1β 20%
• Intracellular Reactive Oxygen Species 20%
• Lipopolysaccharide 20%
• Lipopolysaccharide-induced 20%
• Matrix metalloproteinase-9 (MMP-9) 20%
• Microglial Activation 100%
• Microglial Cells 60%
• Neurodegenerative Diseases 40%
• Neuroinflammatory Diseases 20%
• Nitric Oxide 20%
• Oxide Matrix 20%
• Primary Culture 20%
• Reactive Oxygen Species Levels 20%
• Sesquiterpene Lactones 20%
• Spectroscopic Techniques 20%
• Therapeutic Potential 20%
• Tumor Necrosis Factor-α 20%